nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A5—Dactinomycin—ocular cancer	0.755	1	CbGbCtD
Procainamide—DNMT1—Trans-sulfuration and one carbon metabolism—PSPH—ocular cancer	0.0261	0.106	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—E2F4—ocular cancer	0.00839	0.0343	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—E2F2—ocular cancer	0.00822	0.0336	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—E2F3—ocular cancer	0.00713	0.0291	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—RBBP4—ocular cancer	0.00713	0.0291	CbGpPWpGaD
Procainamide—DNMT1—PRC2 methylates histones and DNA—RBBP4—ocular cancer	0.0068	0.0278	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—TFDP1—ocular cancer	0.00663	0.0271	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00659	0.0269	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CCND3—ocular cancer	0.00601	0.0245	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00572	0.0234	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00572	0.0234	CbGpPWpGaD
Procainamide—ACHE—Monoamine Transport—RBL2—ocular cancer	0.00554	0.0226	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00544	0.0222	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00531	0.0217	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00482	0.0197	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CDK6—ocular cancer	0.00448	0.0183	CbGpPWpGaD
Procainamide—DNMT1—Epigenetic regulation of gene expression—RBBP4—ocular cancer	0.00436	0.0178	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CCND2—ocular cancer	0.00385	0.0157	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—HDAC1—ocular cancer	0.00385	0.0157	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00359	0.0147	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—E2F1—ocular cancer	0.00317	0.0129	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00309	0.0126	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CDK2—ocular cancer	0.00273	0.0112	CbGpPWpGaD
Procainamide—DNMT1—NoRC negatively regulates rRNA expression—HDAC1—ocular cancer	0.00272	0.0111	CbGpPWpGaD
Procainamide—DNMT1—Negative epigenetic regulation of rRNA expression—HDAC1—ocular cancer	0.00266	0.0108	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CDK4—ocular cancer	0.00258	0.0105	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00254	0.0104	CbGpPWpGaD
Procainamide—DNMT1—Epigenetic regulation of gene expression—HDAC1—ocular cancer	0.00236	0.00962	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—RB1—ocular cancer	0.00225	0.00917	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00219	0.00895	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00207	0.00846	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—MDM2—ocular cancer	0.00191	0.00782	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.0018	0.00735	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CDKN1B—ocular cancer	0.00175	0.00714	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CCND1—ocular cancer	0.00167	0.00681	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—CDKN1A—ocular cancer	0.00161	0.00659	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CCND3—ocular cancer	0.00158	0.00647	CbGpPWpGaD
Procainamide—DNMT1—Regulation of retinoblastoma protein—EP300—ocular cancer	0.00154	0.00627	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00153	0.00627	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—SF3B1—ocular cancer	0.00149	0.0061	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00147	0.00602	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00145	0.00591	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CCND3—ocular cancer	0.00141	0.00577	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.0014	0.00572	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00134	0.00546	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00129	0.00528	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CCND3—ocular cancer	0.00129	0.00528	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—CDK4—ocular cancer	0.00116	0.00475	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00107	0.00438	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—EIF1AX—ocular cancer	0.00105	0.0043	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00105	0.00428	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CCND3—ocular cancer	0.00104	0.00427	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—RB1—ocular cancer	0.00101	0.00413	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CCND3—ocular cancer	0.000999	0.00408	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CCND3—ocular cancer	0.00096	0.00392	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CCND3—ocular cancer	0.00096	0.00392	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CCND3—ocular cancer	0.000926	0.00378	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CCND3—ocular cancer	0.000926	0.00378	CbGpPWpGaD
Procainamide—DNMT1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000881	0.0036	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—E2F5—ocular cancer	0.000875	0.00357	CbGpPWpGaD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—ocular cancer	0.000862	0.00352	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—E2F4—ocular cancer	0.000857	0.0035	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—RPL39—ocular cancer	0.000841	0.00343	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—RBL1—ocular cancer	0.000841	0.00343	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—CCND1—ocular cancer	0.000751	0.00307	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—RBBP4—ocular cancer	0.000729	0.00298	CbGpPWpGaD
Procainamide—ACHE—ATF-2 transcription factor network—EP300—ocular cancer	0.000691	0.00282	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CDK4—ocular cancer	0.000681	0.00278	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—TFDP1—ocular cancer	0.000678	0.00277	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—ocular cancer	0.00067	0.00273	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—EIF1AX—ocular cancer	0.000653	0.00267	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CCND3—ocular cancer	0.000651	0.00266	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAQ—ocular cancer	0.000622	0.00254	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000607	0.00248	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CDK4—ocular cancer	0.000607	0.00248	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PSPH—ocular cancer	0.000607	0.00248	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—EIF1AX—ocular cancer	0.000582	0.00238	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000557	0.00228	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CDK4—ocular cancer	0.000555	0.00227	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000541	0.00221	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MAML2—ocular cancer	0.000538	0.0022	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—RPL39—ocular cancer	0.000522	0.00213	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000481	0.00196	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSPH—ocular cancer	0.000477	0.00195	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—RPL39—ocular cancer	0.000466	0.0019	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000454	0.00186	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CDK4—ocular cancer	0.000449	0.00183	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CDK4—ocular cancer	0.000429	0.00175	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSPH—ocular cancer	0.000426	0.00174	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000418	0.00171	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CDK4—ocular cancer	0.000413	0.00169	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CDK4—ocular cancer	0.000413	0.00169	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EP300—ocular cancer	0.000405	0.00165	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CDK4—ocular cancer	0.000398	0.00163	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CDK4—ocular cancer	0.000398	0.00163	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—HDAC1—ocular cancer	0.000394	0.00161	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—HRAS—ocular cancer	0.000388	0.00159	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSPH—ocular cancer	0.00038	0.00155	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EP300—ocular cancer	0.000361	0.00147	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSPH—ocular cancer	0.000355	0.00145	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—CDKN2B—ocular cancer	0.000353	0.00144	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TGFB1—ocular cancer	0.000352	0.00144	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—HRAS—ocular cancer	0.000346	0.00141	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000337	0.00138	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EP300—ocular cancer	0.00033	0.00135	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000325	0.00133	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—HRAS—ocular cancer	0.000316	0.00129	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—ocular cancer	0.000314	0.00128	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000307	0.00126	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000293	0.0012	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000289	0.00118	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—ocular cancer	0.000287	0.00117	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000284	0.00116	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CDK4—ocular cancer	0.00028	0.00114	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—ocular cancer	0.000277	0.00113	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00027	0.0011	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EP300—ocular cancer	0.000267	0.00109	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000259	0.00106	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—ocular cancer	0.000256	0.00105	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EP300—ocular cancer	0.000255	0.00104	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—MDM2—ocular cancer	0.000249	0.00102	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—ocular cancer	0.000247	0.00101	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EP300—ocular cancer	0.000245	0.001	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EP300—ocular cancer	0.000245	0.001	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—ocular cancer	0.000245	0.001	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—AKT1—ocular cancer	0.000245	0.000999	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000241	0.000984	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—ocular cancer	0.000236	0.000966	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—ocular cancer	0.000236	0.000966	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000235	0.000961	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—ocular cancer	0.000235	0.000961	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—ocular cancer	0.000235	0.000961	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000235	0.000959	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—ocular cancer	0.000232	0.000948	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—ocular cancer	0.000227	0.000926	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—ocular cancer	0.000227	0.000926	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—ocular cancer	0.000226	0.000922	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—ocular cancer	0.000222	0.000906	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—MDM2—ocular cancer	0.000222	0.000906	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—AKT1—ocular cancer	0.000218	0.000891	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000216	0.000881	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—ocular cancer	0.000213	0.000871	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—ocular cancer	0.000213	0.000871	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—ocular cancer	0.000206	0.00084	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—ocular cancer	0.000206	0.00084	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—AKT1—ocular cancer	0.000199	0.000814	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MDM2—ocular cancer	0.000198	0.000809	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSPH—ocular cancer	0.000196	0.0008	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000193	0.000789	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GNA11—ocular cancer	0.000191	0.00078	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MDM2—ocular cancer	0.000185	0.000754	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—ocular cancer	0.000183	0.000746	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SAG—ocular cancer	0.00018	0.000734	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000178	0.000727	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GNAQ—ocular cancer	0.000177	0.000725	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—ocular cancer	0.000175	0.000714	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—ocular cancer	0.000168	0.000686	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—ocular cancer	0.000168	0.000686	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—ocular cancer	0.000166	0.000679	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000163	0.000666	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—ocular cancer	0.000162	0.000661	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—ocular cancer	0.000162	0.000661	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—ocular cancer	0.000161	0.000659	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—ocular cancer	0.000159	0.000651	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNA11—ocular cancer	0.000159	0.00065	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F5—ocular cancer	0.000159	0.00065	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000159	0.000649	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F4—ocular cancer	0.000156	0.000636	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—ocular cancer	0.000154	0.00063	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RBL1—ocular cancer	0.000153	0.000624	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GNA11—ocular cancer	0.00015	0.000614	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—ocular cancer	0.000148	0.000605	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—ocular cancer	0.000148	0.000605	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNAQ—ocular cancer	0.000148	0.000604	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—ocular cancer	0.000145	0.00059	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNA11—ocular cancer	0.000144	0.00059	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—ocular cancer	0.000143	0.000584	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—ocular cancer	0.000143	0.000584	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000142	0.00058	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GNAQ—ocular cancer	0.00014	0.000571	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—ocular cancer	0.000137	0.000559	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—ocular cancer	0.000136	0.000557	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNAQ—ocular cancer	0.000134	0.000549	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNA11—ocular cancer	0.000134	0.000548	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F3—ocular cancer	0.000132	0.000541	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000132	0.00054	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNAQ—ocular cancer	0.000125	0.000509	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TFDP1—ocular cancer	0.000123	0.000503	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—ocular cancer	0.000122	0.000497	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNA11—ocular cancer	0.00012	0.000489	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—ocular cancer	0.000114	0.000465	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000113	0.00046	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNA11—ocular cancer	0.000112	0.000456	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNAQ—ocular cancer	0.000111	0.000455	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—ocular cancer	0.000109	0.000444	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNAQ—ocular cancer	0.000104	0.000424	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—ocular cancer	0.000101	0.000414	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000101	0.000411	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—ocular cancer	0.0001	0.00041	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAML2—ocular cancer	9.78e-05	0.0004	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—ocular cancer	9.48e-05	0.000387	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNA11—ocular cancer	8.54e-05	0.000349	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNAQ—ocular cancer	7.94e-05	0.000324	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HDAC1—ocular cancer	7.15e-05	0.000292	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	6.41e-05	0.000262	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—ocular cancer	6.38e-05	0.000261	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNA11—ocular cancer	6.16e-05	0.000252	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F1—ocular cancer	5.89e-05	0.00024	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNAQ—ocular cancer	5.73e-05	0.000234	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—ocular cancer	5.02e-05	0.000205	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—ocular cancer	4.48e-05	0.000183	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—ocular cancer	4e-05	0.000163	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—ocular cancer	3.85e-05	0.000157	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—ocular cancer	3.73e-05	0.000152	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MDM2—ocular cancer	3.56e-05	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—ocular cancer	3.3e-05	0.000135	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	3.25e-05	0.000133	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	3.21e-05	0.000131	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—ocular cancer	3.1e-05	0.000127	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—ocular cancer	3.03e-05	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	3e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—ocular cancer	2.92e-05	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—ocular cancer	2.85e-05	0.000116	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—ocular cancer	2.71e-05	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—ocular cancer	2.48e-05	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—ocular cancer	2.48e-05	0.000101	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—ocular cancer	2.42e-05	9.87e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—ocular cancer	2.25e-05	9.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—ocular cancer	2.06e-05	8.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—ocular cancer	2.04e-05	8.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—ocular cancer	1.95e-05	7.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—ocular cancer	1.72e-05	7.04e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—ocular cancer	1.24e-05	5.08e-05	CbGpPWpGaD
